Three-quarters of all chronic hepatitis C cases in the U.S afflict people over 50. But in recent years, new infections have tripled among people in their 20s. Health officials call it a side effect of the opioid epidemic.
Pauline Bartolone (@pbartolone) from Kaiser Health News reports on a program that’s trying to reach these young people who use drugs, outside the traditional health care setting.
Copyright 2021 NPR. To see more, visit https://www.npr.org.